Double-balloon precise quantitative drug injection catheter

A double-balloon and catheter technology, applied in the direction of balloon-shaped catheters and catheters, can solve the problems of low output, limited variety, high cost, etc., and achieve the effects of precise control, uniform drug delivery and good therapeutic effect

Pending Publication Date: 2019-10-01
THE FIRST AFFILIATED HOSPITAL OF HENAN UNIV OF TCM
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Drug balloons currently on the market can release drugs to the local blood vessel wall, reduce the time and intensity of antiplatelet therapy, and avoid implanting foreign bodies in the body, and are used to treat ISR. Patients with high bleeding risk, patients who are taking oral anticoagulants or have undergone recent surgery, patients with a history of subacute stent thrombosis, and patients who refuse to implant foreign bodies in the body, the surface of the balloon is coated with fixed drugs, but the coating Drugs such as paclitaxel or rapamycin are mostly anti-proliferative drugs for smooth muscle cells, which play an important role in the field of interventional therapy for coronary heart disease by achieving local treatment of plaque and prevention of ISR. However, there are still some problems with drug-coated balloons. : 1. The types of drug-coated balloons on the market are limited; 2. Uniform and precise drug administration cannot be achieved; 3. Repeated drug administration is not possible; 4. Expensive
Injection balloons are currently only used in animal experiments, (1) Clearway, with very little output and limited varieties, cannot be transformed into clinical applications, and the injection volume cannot be precisely controlled; (2) Middle segment perfusion with blocking balloons at both ends The balloon can only inject the drug into the blood vessel lumen without any effect on the blood vessel wall

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Double-balloon precise quantitative drug injection catheter

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0010] Implementation: The double-balloon precise quantitative drug injection catheter as shown in the figure includes a guide wire 8, a main catheter 1 and a balloon. The balloon is composed of an inner balloon 7 and an outer balloon 5. According to the characteristics of the balloon The inner balloon 7 described above is compliant, the outer balloon 5 is non-compliant, the outer balloon 5 is wrapped outside the inner balloon 7, and the outer wall of the outer balloon 5 is provided with several evenly distributed mastoids 4 , The mastoid 4 is provided with a medicine outlet hole 6 . The main catheter 1 is placed in the middle of the outer balloon 5 and the inner balloon 7, the guide wire 8 is placed in the main catheter 1, and the guide wire 8 is passed through the guide wire inlet 10 provided on the main catheter 1 from the guide wire Outlet 13 passes through, and described main catheter 1 is provided with pressurization catheter 3 and drug injection catheter 2, and the outl...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a double-balloon precise quantitative drug injection catheter. The catheter comprises a guide wire, a main catheter body and a balloon, the balloon is composed of an inner balloon body and an outer balloon body, the main catheter body is arranged in the middle of the outer balloon body and the inner balloon body, the guide wire is arranged in the main catheter body, the guide wire penetrates through a guide wire inlet formed in the main catheter body and penetrates out from a guide wire outlet, the main catheter body is internally provided with a pressure catheter bodyand a drug injection catheter body, the outlet end of the drug injection catheter body penetrates through the catheter and placed in a gap between the inner balloon body and the outer balloon body, the other end of the drug injection catheter body is connected with a drug injection pump, ad a control valve is arranged on the drug injection catheter body. The outlet end of the pressure catheter body penetrates through the main catheter body to be communicated with the inner balloon body, and the other end of the pressure catheter body is connected with a pressure pump. Accordingly, precise control over the dosage of applied drugs can be achieved, the drug injection amount and pressure size are controlled through a drug injection pipe and a pressure pipe respectively, drugs are injected intothe endovascular wall, dosing is uniform, the drugs are not wasted, the drugs can be fully utilized, drug injection can be conducted repeatedly, and the type of drug injection can be changed.

Description

technical field [0001] The invention belongs to medical devices, in particular to a catheter for double-balloon precise and quantitative drug injection. Background technique [0002] In-stent restenosis (ISR) is a major problem in the PCI era of coronary heart disease today. In the current ISR treatment plan, there are many risk factors and contraindications for coronary artery bypass grafting, and re-implantation of stents may cause Re-ISR and other multiple stent implantation risks, drug-eluting balloon (DCB) treatment avoids foreign body implantation, and preserves the opportunity for follow-up treatment if necessary. Drug balloons currently on the market can release drugs to the local blood vessel wall, reduce the time and intensity of antiplatelet therapy, and avoid implanting foreign bodies in the body, and are used to treat ISR. Patients with high bleeding risk, patients who are taking oral anticoagulants or have undergone recent surgery, patients with a history of s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61M25/10
CPCA61M25/1002A61M25/1006A61M25/10182A61M25/10183A61M2025/105
Inventor 关怀敏尚莎莎陈玉善解金红罗明华王贺柴爽爽
Owner THE FIRST AFFILIATED HOSPITAL OF HENAN UNIV OF TCM
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products